Trial Profile
A Phase 3, Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 11 to 55 Years of Age in Korea
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Jan 2016
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
- Indications Meningococcal infections
- Focus Pharmacodynamics
- 19 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jan 2011 New trial record